• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Horizon Technology Finance and Monroe Capital Support OSSIO with a $50 Million Credit Facility for Continued Growth

    2/11/26 6:00:00 AM ET
    $HRZN
    Finance: Consumer Services
    Finance
    Get the next $HRZN alert in real time by email

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon"), together with Monroe Capital LLC ("Monroe"), today announced the closing of an initial $40 million senior credit facility for Ossio Inc. ("OSSIO"), with an additional $10 million available to support future growth.

    Founded in 2014, OSSIO is an orthopedics company committed to transforming the surgical experience for patients, physicians, providers and payors. The company's vision is to provide the first credible replacement for metal implants in the multibillion-dollar global orthopedic fixation market with OSSIOfiber Intelligent Bone Regeneration Technology. OSSIO conducts product development and manufacturing in Caesarea, Israel, with commercial operations based in Palmetto, FL.

    "We are thrilled to partner with Horizon Technology Finance and Monroe Capital on this growth capital investment. We look forward to executing on our strategy to expand our orthopedic fixation technology globally," commented Brian Verrier, Chief Executive Officer of OSSIO. "This partnership combines deep healthcare technology expertise with growth capital. Financing from the Horizon and Monroe platform provides the resources needed to accelerate expansion while preserving the company's mission of transforming the orthopedic experience for patients."

    "We are excited to partner with Brian and the OSSIO team as they broaden their global impact in orthopedic medical technology," said Paul Seitz, Chief Investment Officer of Horizon. "This investment reflects Horizon's commitment to supporting innovative, venture growth companies through strategic financing. OSSIO marks another Horizon investment within the Israeli technology ecosystem."

    "Monroe continues to see exceptional innovation emerging from the Israeli life sciences sector, and OSSIO stands out as a leading force in orthopedic and regenerative technology," said Mark Solovy, Managing Director and Co-Head, Technology Finance Group at Monroe Capital. "Its disruptive, metal-free bone regeneration solutions align directly with our technology finance vertical, and we are proud to support Brian and his team as they globally scale OSSIO's impact."

    About Horizon Technology Finance

    Horizon Technology Finance Corporation (NASDAQ:HRZN), externally managed by Horizon Technology Finance Management LLC, an affiliate of Monroe Capital, is a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of Horizon is to maximize its investment portfolio's return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Horizon is headquartered in Farmington, Connecticut, with a regional office in Pleasanton, California, and investment professionals located throughout the U.S. Monroe Capital is a premier asset management firm specializing in private credit markets across various strategies, including direct lending, technology finance, venture debt, opportunistic, structured credit, real estate and equity. To learn more, please visit horizontechfinance.com.

    About Monroe Capital

    Monroe Capital LLC ("Monroe") is a premier asset management firm specializing in private credit markets across various strategies, including direct lending, technology finance, venture debt, alternative credit solutions, structured credit, real estate and equity. Since 2004, the firm has been successfully providing capital solutions to clients in the U.S. and Canada. Monroe prides itself on being a value-added and user-friendly partner to business owners, management, and both private equity and independent sponsors. Monroe's platform offers a wide variety of investment products for both institutional and high net worth investors with a focus on generating high quality "alpha" returns irrespective of business or economic cycles. The firm is headquartered in Chicago and has 12 locations throughout the United States, Middle East, Asia and Australia.

    Monroe has been recognized by both its peers and investors with various awards including GrowthCap Advisory's 2025 Top Private Credit Firm List; Inc.'s 2025 Founder-Friendly Investors List; DealCatalyst as the 2025 Most Innovative Private Credit CLO Manager of the Year; Private Debt Investor as the 2024 Lower Mid-Market Lender of the Year, Americas and 2023 Lower Mid-Market Lender of the Decade; Global M&A Network as the 2024 Lower Mid-Markets Lender of the Year, Americas; Korean Economic Daily as the 2022 Best Performance in Private Debt – Mid Cap; Creditflux as the 2021 Best U.S. Direct Lending Fund; and Pension Bridge as the 2020 Private Credit Strategy of the Year. For more information and important disclaimers, please visit www.monroecap.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260211040682/en/

    For more information, please contact:

    Investor Relations:

    ICR

    Garrett Edson

    ir@horizontechfinance.com

    (860) 284-6450

    Media Relations:

    ICR

    Chris Gillick

    HorizonPR@icrinc.com

    (646) 677-1819

    Zia Uddin

    Monroe Capital LLC

    312-523-2374

    zuddin@monroecap.com

    Daniel Abramson

    Gregory

    857-305-8441

    dabramson@gregoryagency.com

    Get the next $HRZN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HRZN

    DatePrice TargetRatingAnalyst
    5/13/2025$7.00Neutral
    B. Riley Securities
    4/30/2025$6.50Neutral → Sell
    Compass Point
    12/17/2024$8.25Sell → Neutral
    Compass Point
    2/28/2024Buy → Neutral
    Ladenburg Thalmann
    1/8/2024$11.00Neutral → Sell
    B. Riley Securities
    10/17/2023$10.00Neutral → Sell
    Compass Point
    9/27/2023$11.00 → $10.50Sell → Neutral
    Compass Point
    8/4/2023$11.00Neutral → Sell
    Compass Point
    More analyst ratings

    $HRZN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Seitz Paul G claimed ownership of 600 shares (SEC Form 3)

    3 - Horizon Technology Finance Corp (0001487428) (Issuer)

    6/26/25 2:54:53 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Director Balkin Michael bought $170,600 worth of shares (20,000 units at $8.53) (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    12/17/24 1:23:10 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    President Michaud Gerald A. bought $74,519 worth of shares (8,000 units at $9.31), increasing direct ownership by 5% to 169,309 units (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    12/2/24 11:38:46 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities resumed coverage on Horizon Technology Finance with a new price target

    B. Riley Securities resumed coverage of Horizon Technology Finance with a rating of Neutral and set a new price target of $7.00

    5/13/25 10:04:46 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance downgraded by Compass Point with a new price target

    Compass Point downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $6.50

    4/30/25 8:07:52 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance upgraded by Compass Point with a new price target

    Compass Point upgraded Horizon Technology Finance from Sell to Neutral and set a new price target of $8.25

    12/17/24 8:05:36 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Balkin Michael bought $170,600 worth of shares (20,000 units at $8.53) (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    12/17/24 1:23:10 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    President Michaud Gerald A. bought $74,519 worth of shares (8,000 units at $9.31), increasing direct ownership by 5% to 169,309 units (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    12/2/24 11:38:46 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Director Savage Joseph J bought $88,150 worth of shares (9,500 units at $9.28), increasing direct ownership by 19% to 59,500 units (SEC Form 4)

    4 - Horizon Technology Finance Corp (0001487428) (Issuer)

    11/14/24 4:23:08 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Horizon Technology Finance and Monroe Capital Support OSSIO with a $50 Million Credit Facility for Continued Growth

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon"), together with Monroe Capital LLC ("Monroe"), today announced the closing of an initial $40 million senior credit facility for Ossio Inc. ("OSSIO"), with an additional $10 million available to support future growth. Founded in 2014, OSSIO is an orthopedics company committed to transforming the surgical experience for patients, physicians, providers and payors. The company's vision is to provide the first credible replacement for metal implants in the multibillion-dollar global orthopedic fixation market with OSSIOfiber Intelligent Bone Regeneration Technology. OSSIO conducts product development and manufacturing in Caesarea,

    2/11/26 6:00:00 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, today announced it has provided a $50 million venture loan facility to Pelthos Therapeutics Inc. (NYSE:PTHS) ("Pelthos"), with an initial funding of $30 million, and up to $20 million to support future growth. Pelthos is a publicly traded biopharmaceutical company that is licensed to commercialize ZELSUVMI™ (berdazimer) topical gel, an FDA-approved treatment of molluscum contagiosum, a common skin infection characterized by small bumps or lesions. ZELSUVMI delivers nitric oxide directly to the affected skin or tissue via the Nitricil platform, which enables the gel to slowly a

    1/15/26 4:10:00 PM ET
    $HRZN
    $PTHS
    Finance: Consumer Services
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance

    DURHAM, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE:PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs ("Pelthos"), today announced it has secured financing from Horizon Technology Finance Corporation ("Horizon") (NASDAQ:HRZN), an affiliate of Monroe Capital, with an initial funding of $30 million, and up to $20 million to support future growth. "We believe this transaction with Horizon gives Pelthos the flexibility and resources to accelerate the commercialization of our cutaneous infectious disease product portfolio, strengthens our balance sheet, and most importantly, brings ZELSUVMI, the f

    1/13/26 8:30:00 AM ET
    $HRZN
    $PTHS
    Finance: Consumer Services
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $HRZN
    SEC Filings

    View All

    SEC Form 40-33 filed by Horizon Technology Finance Corporation

    40-33 - Horizon Technology Finance Corp (0001487428) (Filer)

    2/6/26 5:13:08 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    SEC Form 25-NSE filed by Horizon Technology Finance Corporation

    25-NSE - Horizon Technology Finance Corp (0001487428) (Subject)

    1/29/26 3:17:43 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    SEC Form 424B3 filed by Horizon Technology Finance Corporation

    424B3 - Horizon Technology Finance Corp (0001487428) (Filer)

    1/20/26 9:21:39 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    Leadership Updates

    Live Leadership Updates

    View All

    Horizon Technology Finance Appoints Paul Seitz as Chief Investment Officer

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or "HRZN") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity backed and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it has appointed Paul Seitz as its new Chief Investment Officer. Concurrently, Daniel Devorsetz has stepped down as Chief Operating Officer and Chief Investment Officer, but will remain involved with the Company through September 2025. "We are thrilled to welcome Paul as our new Chi

    6/9/25 4:15:00 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Vesta Healthcare Raises $65 Million in Financing to Propel Growth

    Vesta Healthcare, a virtual care provider group for people with home care, today announced the close of $65 million in a Series C round with new debt financing. The equity round was led by Boston-based RA Capital Management, with participation from Oak HC/FT, Chrysalis Ventures, CareCentrix/Walgreens, Nationwide, Kaiser Permanente Ventures, Lux Capital, Generator Ventures, Deerfield Management and others. Debt financing was provided by Horizon Technology Finance Corporation, an affiliate of Monroe Capital. "The home is the last frontier of healthcare, and caregivers are the most vital yet disconnected resource in the delivery system," said Randy Klein, CEO of Vesta Healthcare. "We're pr

    9/4/24 8:00:00 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance Appoints Daniel Devorsetz as Chief Operating Officer

    FARMINGTON, Conn., June 9, 2021 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon," or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that it has appointed Daniel S. Devorsetz as Chief Operating Officer effective immediately. In addition, Devorsetz has concurrently been appointed as Chief Operating Officer of Horizon's external investment advisor, Horizon Technology Finance Management LLC (the "Advisor" or "HTFM"). He currently serves as Chief Investment Of

    6/9/21 4:15:00 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    $HRZN
    Financials

    Live finance-specific insights

    View All

    Horizon Technology Finance Announces Third Quarter 2025 Financial Results

    - Third Quarter 2025 Net Investment Income per Share of $0.32; NAV per Share of $7.12 - - Debt Portfolio Yield of 18.6% - - HRZN Ends Quarter with Committed Backlog of $119 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through March 2026 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial

    10/28/25 4:15:00 PM ET
    $HRZN
    $MRCC
    Finance: Consumer Services
    Finance
    Investment Managers

    Horizon Technology Finance to Announce Third Quarter 2025 Financial Results

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the third quarter ended September 30, 2025 on Tuesday, October 28, 2025, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, October 29, 2025, at 9:00 a.m. ET. The conference call will

    10/14/25 4:15:00 PM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Horizon Technology Finance Announces Second Quarter 2025 Financial Results

    - Second Quarter 2025 Net Investment Income per Share of $0.28; NAV per Share of $6.75 - - Debt Portfolio Yield of 15.8% - - HRZN Ends Quarter with Committed Backlog of $149 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through December 2025 - - Announced Merger with Monroe Capital Corp (NASDAQ:MRCC) - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and serv

    8/7/25 4:10:00 PM ET
    $HRZN
    $MRCC
    Finance: Consumer Services
    Finance
    Investment Managers